Cancer drug shortages persist, hampering patient care and highlighting lasting impacts of platinum chemotherapy

The STAT+ newsletter reports that cancer treatment centers continue to struggle with ongoing shortages of key oncology drugs, forcing clinicians to alter or delay therapy for patients.

These shortages are described as a persistent problem that disrupts routine care and adds logistical challenges for hospitals and physicians.

Researchers highlighted new data showing that platinum‑based chemotherapy can leave lasting genetic changes in children, raising concerns about long‑term effects. The article also noted unexpected failures of a heart‑failure medication and observed that pharmaceutical sales representatives remain deeply embedded in medical practice despite the broader supply issues.